Literature DB >> 4504846

Elution of "blocking factors" from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes.

H O Sjögren, I Hellström, S C Bansal, G A Warner, K E Hellström.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4504846     DOI： 10.1002/ijc.2910090205

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  36 in total

1.  Lymphocytotoxicity to tumor target cells and interference of serum factors or tumor antigen with lymphocytotoxicity in patients suffering from different stages of breast carcinoma.

Authors:  H Warnatz; D Lackner; E Eder; F Scheiffarth; M Gruhl; O Bischoff
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-02-25

Review 2.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

3.  Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial).

Authors:  H M Jansen; T H The; G C de Gast; M T Esselink; A M van der Wal; N G Orie
Journal:  Thorax       Date:  1978-08       Impact factor: 9.139

4.  Immunoglobulin and complement inclusions in peripheral blood polymorphonuclear leucocytes of patients with bronchial carcinoma.

Authors:  H M Jansen; T H The; G C de Gast; H A Huiges; M T Esselink; A M van der Wal; N G Orie
Journal:  Thorax       Date:  1977-12       Impact factor: 9.139

Review 5.  Humoral factors influencing cell-mediated immune responses to tumour-associated antigens.

Authors:  R W Baldwin; M J Embleton; R A Robins
Journal:  Proc R Soc Med       Date:  1973-05

6.  Significance of serum factors modifying cellular immune responses to growing tumours.

Authors:  R W Baldwin; M R Price; R A Robins
Journal:  Br J Cancer Suppl       Date:  1973-08

7.  Circulating immune complexes in gastric cancer patients and their effect on lymphocyte mitogenesis (the first report).

Authors:  Y Osaki; S Koga; M Maeta; N Shimizu; H Kanayama; R Hamazoe
Journal:  Jpn J Surg       Date:  1984-11

8.  Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes.

Authors:  C J Punt; J A Barbuto; H Zhang; W J Grimes; K D Hatch; E M Hersh
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

9.  Lymphocytic infiltration in long-survival glioblastomas: possible host's resistance.

Authors:  N Di Lorenzo; L Palma; S Nicole
Journal:  Acta Neurochir (Wien)       Date:  1977       Impact factor: 2.216

10.  Immunosuppressive acidic protein (IAP) in gastric cancer patients.

Authors:  N Shimizu; T Yamane; T Karino; R Hamazoe; Y Osaki; H Kanayama; M Maeta; S Koga
Journal:  Jpn J Surg       Date:  1983-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.